BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16537119)

  • 1. Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies.
    Biondi A; Rizzari C; Valsecchi MG; De Lorenzo P; Aricò M; Basso G; Locatelli F; Lo Nigro L; De Rossi G; Masera G
    Haematologica; 2006 Apr; 91(4):534-7. PubMed ID: 16537119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G
    Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
    Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center].
    Doubek M; Mayer J; Korístek Z; Protivánková M; Brychtová Y; Oborilová A; Král Z; Klabusay M; Tomíska M; Buchtová I; Vorlícek J
    Cas Lek Cesk; 2002 Mar; 141(4):122-6. PubMed ID: 12046256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
    Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
    Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
    [No Abstract]   [Full Text] [Related]  

  • 6. [High risk acute lymphoblastic leukaemia in children. Preliminary report after introducing a new version of New York (1997) protocol adjusted to the age of the patients. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].
    Skoczen S; Klus K; Armata J; Kowalczyk J; Wisniewska-Slusarz H; Kolecki P; Derwich K; Matysiak M; Krauze A; Rokicka-Milewska R; Pawelec K; Boguslawska-Jaworska J; Juszczak K; Pisarek J; Sońta-Jakimczyk D; Tomaszewska R; Łuszczynska A; Wysocki M; Styczyński J
    Med Wieku Rozwoj; 2000; 4(1 Suppl 2):23-32. PubMed ID: 12021459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
    Ziino O; Russo D; Orlando MA; Benigno V; Locatelli F; Aricò M
    Med Pediatr Oncol; 2002 Jul; 39(1):32-4. PubMed ID: 12116076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute lymphoblastic leukemia in adults: results of the DATOP-79 protocol].
    Ribera JM; Grañena A; Sierra J; Urbano-Ispizua A; Brugués R; Rozman C
    Med Clin (Barc); 1988 Nov; 91(17):653-7. PubMed ID: 3230971
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of high-risk acute lymphoblastic leukemia with protocols PETHEMA LAL 7/78 and LAL 17/84.
    Ortega JJ; Javier G; Olivé T
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():72-83. PubMed ID: 3214043
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of acute lymphoblastic leukemia].
    Paolucci G; Rosito P
    Minerva Pediatr; 1971 Nov; 23(44):1851-69. PubMed ID: 4950250
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary results of BFM 96 protocol in treatment of childhood ALL relapse in the experience of the Polish Paediatric Leukaemia /Lymphoma Study Group].
    Chybicka A; Bogusławska-Jaworska J; Gorczyńska E; Armata J; Balcerska A; Balwierz W; Bubala H; Filiks-Litwin B; Kołecki P; Kowalczyk J; Łukowska K; Matysiak M; Rokicka-Milewska R; Rola-Kurc E; Stencel D; Sonta-Jakimczyk D; Strojny W; Wachowiak J; Wieczorek M; Wysocki M; Zelenay E
    Med Wieku Rozwoj; 2000; 4(1 Suppl 2):43-8. PubMed ID: 12021461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of acute lymphoblastic leukaemia in Ibadan, Nigeria.
    Okpala IE; Olatunji PO; Okunade MA; Ogunsanwo BA; Jeje OM; Shokunbi WA; Essien EM
    Afr J Med Med Sci; 1990 Dec; 19(4):313-7. PubMed ID: 2128003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of anthracyclines in infants in the treatment of acute lymphoblastic and non-lymphoblastic leukemias].
    Leverger G; Bancillon A; Schaison G
    Pathol Biol (Paris); 1987 Jan; 35(1):87-90. PubMed ID: 3550617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in the treatment of acute leukemia in adults].
    Pawelski S
    Acta Haematol Pol; 1973; 4(4):283-9. PubMed ID: 4772918
    [No Abstract]   [Full Text] [Related]  

  • 15. Summary: recent advances in the treatment of acute leukemia and Burkitt's tumor.
    Holland JF
    Cancer Res; 1967 Dec; 27(12):2633-5. PubMed ID: 5237355
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term results of 2 therapeutic protocols in children with acute lymphoblastic leukemia of usual risk. Experience at the 20th of November National Medical Center].
    López-Hernández MA; de Diego Flores-Chapa J; Borbolla-Escoboza JR; Trueba-Christy E; Carrillo-Rosales T; González-Avante M
    Gac Med Mex; 1998; 134(2):145-51. PubMed ID: 9618993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of adult acute lymphoblastic leukemia by KHALL-93--long-term outcome].
    Usuki K; Adachi Y; Kazama K; Iki S; Urabe A
    Gan To Kagaku Ryoho; 2000 Aug; 27(9):1397-402. PubMed ID: 10969595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fourteen relapses of acute lymphoblastic leukaemia in a child.
    Armata J; Wyszkowski J
    Haematologia (Budap); 1973; 7(3):413-7. PubMed ID: 4524438
    [No Abstract]   [Full Text] [Related]  

  • 19. Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and levamisole maintenance.
    Morrison FS; Kopecky KJ; Head DR; Athens JW; Balcerzak SP; Gumbart C; Dabich L; Costanzi JJ; Coltman CA; Saiki JH
    Leukemia; 1992 Jul; 6(7):708-14. PubMed ID: 1625490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy].
    Hirano M; Uetani T; Morita A; Sako F; Koie K
    Saishin Igaku; 1971 Oct; 26(10):2034-41. PubMed ID: 5288692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.